Clinical trial
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
NCT07040189 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
- Lead sponsor
- Wuerzburg University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 25, 2025
- Completion date
- December 31, 2026
- Enrollment
- 51 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
gi cancer, multiple myeloma, taste disorders